Open Access

Prevalence and triggers of allergic rhinitis in the United Arab Emirates

  • Bassam Mahboub1,
  • Suleiman Al-Hammadi2Email author,
  • Vijayshree P Prakash1,
  • Nabil Sulaiman3,
  • Michael S Blaiss4,
  • Abdulla Al Redha5 and
  • Deepa M Vats5
World Allergy Organization Journal20147:19

https://doi.org/10.1186/1939-4551-7-19

Received: 13 December 2013

Accepted: 10 July 2014

Published: 1 August 2014

Abstract

Background and objectives

Allergic rhinitis is a morbid condition that is frequently overlooked by patients and physicians. This type of atopy has not been adequately investigated in the United Arab Emirates.

Methods

This cross-sectional, population-based observational study was conducted in the seven Emirates (Abu Dhabi, Dubai, Sharjah, Ajman, Umm Al-Quwain, Ras Al-Khaimah, and Fujairah). It used the European Community Respiratory Health Survey (ECRHS II) to screen for allergic rhinitis in people living in this region.

Results

Symptoms of allergic rhinitis were present in 85 (7%) of the 1,229 study population. Only 33 (39%) patients received treatment. Seventy-six (89%) patients had asthma. Thirty-seven (44%) patients were poly-sensitized. Symptoms were aggravated by dust (59%), grass/pollens (44%) and proximity to animals (21%). Winter was the peak season (37%), followed by spring (30%), autumn (18%) and summer (15%). Grass/pollen allergies were clustered in the winter, spring and summer (p ≤ 0.001). Dust was non-seasonal (p ≥ 0.121) and animal allergy was worse in the winter (p = 0.024) and spring (p = 0.044). Spring symptoms were less common in people living in the inner city (p = 0.003).

Conclusions

At least 7% of the studied population had allergic rhinitis. Most (71%) of these patients had environmental triggers and remained untreated. Allergic rhinitis awareness and measures to control allergens and dust are needed. The impact of preventing allergic rhinitis on other common atopies in the region deserves future studies.

Keywords

Allergens Nasal mucosa Pollen Air pollution Fine dust Constructions Gulf region

Introduction

Allergic rhinitis is an IgE-mediated inflammation of the nasal mucosa that is frequently triggered by inhaled allergens [1]. The symptoms are often ignored by patients and physicians, and most affected individuals do not report their complaints or seek treatments [2]. Clinical findings include recurrent sneezing, rhinorrhea, nasal congestion (stuffy nose), nasal/palatal itching, and itchy/watery eyes. These manifestations are associated with daytime somnolence, disturbed sleep, reduced activity and absenteeism from school or work [3]. Patients may also have other atopies (e.g., sinusitis, conjunctivitis, asthma, and atopic dermatitis) [4] or demonstrate a poor response to atopy treatment [1].

Prevalence of allergic rhinitis has been recently estimated by the World health organization (http://www.who.int/gard/publications/GARDGMreport2013.pdf). A reported prevalence of self-reported seasonal and perennial nasal symptoms in the United States is 30% [5], in Europe 20% [6, 7], in different parts of the Middle East 9% [8], and in Al-Ain City (Abu Dhabi) 36% [9]. This study used personal interviews and bilingual English and Arabic version of the European Community Respiratory Health Survey (ECRHS II) to investigate the prevalence and triggers of allergic rhinitis in the United Arab Emirates (UAE).

Method

This cross-sectional, population-based observational study enrolled adults from regions across the entire UAE. The participants (n = 1,229; 20% citizens and 80% expatriates) were random representatives of the inner cities, suburbs, small towns, villages, and farms. The study sample size was calculated based on the “UAE Census Estimation - 2009”, as previously described [10]. There were 455 (37%) females and 774 (63%) males.

ECRHS II was used to identify individuals with nasal or eye symptoms that were consistent with allergic rhinitis. A face-to-face community survey was conducted across the seven Emirates (Abu Dhabi, Dubai, Sharjah, Ajman, Umm Al-Quwain, Ras Al-Khaimah, and Fujairah) between January 2010 and March 2010. All participants were informed about the voluntary nature of the study and a signed written informed consent was obtained from each participant. There were no exclusion criteria. The research protocol was approved by the Clinical Research Ethics Authority of Dubai.

The ECRHS II screener questionnaire was translated to Arabic and the interviews were conducted using a side by side bilingual (English/Arabic) version (Additional file 1). Patient reports of environmental triggers and use of nasal allergy medications were noted. All interviewers were trained prior to the survey. Each interviewer conducted two pilot interviews and reviewed the completed questionnaires with a supervisor to identify and resolve inconsistencies. All materials were piloted as per standard quality control procedures. Each interviewer interviewed at least ten subjects and the process was witnessed by an experienced person who could clarify doubtful points. Completed questionnaires were checked regionally and again centrally for accuracy.

Participants who answered “yes” to at least one of the four designated questions (Question 1, 4, 5, or 7) in the screener questionnaire were invited to answer the modified, bilingual version (English and Arabic) of ECRHS II main questionnaire (Additional file 2). The modification included local/regional nuances, such as shisha smoking and use of trade/brand names of anti-allergic drugs or nasal sprays. Participants who also answered “yes” to Question 7 were considered having allergic rhinitis. The main questionnaire was administered immediately after the screening, or follow-up appointments were arranged between the interviewer and respondent to complete the 86 questions of the questionnaire.

Question one was: Have you had wheezing or whistling in your chest at any time in the last 12 months? Question four was: Have you been woken by an attack of coughing at any time in the last 12 months? Question five was: Have you had an attack of asthma in the last 12 months? Question seven was: Do you have any nasal allergies including hay fever?

The Statistical Package for Social Sciences (SPSS) software version 19.0 for Windows was used. Logistic regression analysis was used to identify independent predictors of triggers (dust, grass/pollens, and animal proximity) and seasons of symptoms. P < 0.05 was considered significant.

Results

One hundred eighty-eight (15%) of the 1,229 participants answered “yes” to Question 1, 4, 5, or 7, in the screener questionnaire (see above). Of those, 85 (7%) patients answered “yes” to Question 7, and were diagnosed as having allergic rhinitis. Twenty-two (27%) patients were ≤19 years of age, 46 (55%) were 20–44 years of age, and 15 (18%) were ≥45 years of age; two patients did not report their ages. Fifty-eight percent of the patients lived in inner cities, 25% in suburbs, 8% in small towns, 7% in rural areas and 2% in farms.

Seventy-six (89%) of the 85 patients had asthma. Sixty-one percent of the patients did not receive any treatment, 13% received steroid nasal spray, 5% received oral antihistamines and 14% received steroid nasal spray plus antihistamines.

Thirty-seven (44%) patients were poly-sensitized. House-hold dust was a common trigger; 50 (59%) patients reported worsening of symptoms in dusty areas of their homes or near dusty pillows, rugs or duvets. Grass/pollens were triggers in 37 (44%) patients and proximity to animals in 18 (21%) patients (Table 1). Twelve patients (14%) reported no worsening of the nasal symptoms on exposure to dust, grass/pollens or animals; however, their asthma worsened when exposed to these allergens/irritants. Nine (11%) patients reported no worsening of either nasal or asthma symptoms following dust, grass/pollen or animal exposure.
Table 1

Triggers and seasonality of the allergic rhinitis

 

Males

Females

Total

N = 774

N = 455

N = 1229

n (%)

n (%)

n (%)

Triggers

Dust only

13 (29)

9 (23)

22 (26)

None specified

13 (29)

8 (20)

21 (25)

Dust + grass/pollens

7 (16)

10 (25)

17 (20)

Dust + grass/pollens + animals

4 (8)

5 (13)

9 (11)

Grass/pollens only

3 (7)

4 (10)

7 (8)

Grass/pollens + animals

2 (4)

2 (5)

4 (4)

Animals only

1 (2)

2 (5)

3 (4)

Dust + animals

2 (4)

0

2 (2)

Seasonality

Winter

15 (37)

14 (38)

29 (37)

Spring

13 (32)

10 (27)

23 (30)

Summer

6 (15)

6 (16)

12 (15)

Autumn

7 (17)

7 (19)

14 (18)

Values are number (%) of patients with available data. Seasonality was not reported in seven patients.

Forty-eight percent of the patients lived near industrial areas or constructions; 74% reported constant/frequent passing of vehicles near their homes. Forty-six percent of patients made efforts to minimize exposure to dust and dust-mites by changing carpets and using anti-mite sprays or covers.

Thirty-seven percent of patients reported worsening of symptoms in the winter (November-February) and 30% reported worsening of symptoms in the spring (March-May). Summer and autumn were less frequent seasons, since many people traveled outside the country in the summer and returned in early autumn (Table 1). Three (4%) patients reported perennial symptoms and four (5%) reported no relation to seasons.

Grass/pollen allergies were clustered in the winter, spring and summer (p ≤0.001), Table 2. Dust was non-seasonal (p ≥0.121) and animal allergy was in the winter (p = 0.024) and spring (p = 0.044), Table 2. Living in the inner city was not a predictor of any trigger (p ≥0.374), and spring symptoms were less common in people living in the inner city (p = 0.003), Table 3.
Table 2

Simple logistic regression of triggers of allergic rhinitis vs. season

Variable

Trigger

OR

95% CI for OR

P-value

Winter

Dust

   

Yes

22 (76)

2.2

0.8 – 6.0

0.121

No

33 (59)

Winter

Grass/pollens

   

Yes

26 (90)

28.7

7.5 – 110.2

<0.001

No

13 (23)

Winter

Animal proximity

   

Yes

11 (38)

3.2

1.1 – 9.0

0.024

No

9 (16)

Spring

Dust

   

Yes

15 (65)

1.0

0.4 – 2.8

0.952

No

40 (65)

Spring

Grass/pollens

   

Yes

19 (83)

10.0

3.0 – 33.2

<0.001

No

20 (32)

Spring

Animal proximity

   

Yes

9 (39)

3.0

1.0 – 8.6

0.044

No

11 (18)

Summer

Dust

   

Yes

10 (83)

3.2

0.7 – 15.6

0.137

No

44 (61)

Summer

Grass/pollens

   

Yes

11 (92)

18.3

2.2 – 150.0

<0.001

No

27 (38)

Summer

Animal proximity

   

Yes

4 (33)

1.8

0.5 – 6.6

0.403

No

16 (22)

Autumn

Dust

   

Yes

10 (71)

1.5

0.4 – 5.2

0.541

No

44 (63)

Autumn

Grass/pollens

   

Yes

10 (71)

3.8

1.0 – 13.1

0.039

No

28 (40)

Autumn

Animal proximity

   

Yes

4 (29)

1.4

0.4 – 4.9

0.647

No

16 (23)

Values are n (%). OR, odds ratio; CI, confidence interval.

Table 3

Simple logistic regression of triggers of allergic rhinitis vs. living area

Variable

Trigger or season

OR

95% CI for OR

P-value

Inner city

Dust

   

Yes

32 (67)

1.2

0.5 – 3.0

0.667

No

23 (62)

Inner city

Grass/pollens

   

Yes

20 (42)

0.7

0.3 – 1.6

0.374

No

19 (51)

Inner city

Animal proximity

   

Yes

13 (27)

1.6

0.6 – 4.5

0.379

No

7 (19)

Inner city

Winter

   

Yes

33 (69)

1.3

0.5 – 3.3

0.525

No

23 (62)

Inner city

Spring

   

Yes

29 (60)

0.2

0.1 – 0.6

0.003

No

33 (81)

Inner city

Summer

   

Yes

43 (92)

3.0

0.8 – 10.8

0.088

No

29 (78)

Inner city

Autumn

   

Yes

39 (83)

0.9

0.3 – 3.0

0.922

No

31 (84)

Values are n (%). Living area was inner city vs. other areas. OR, odds ratio; CI, confidence interval.

Discussion

Widespread variations in the prevalence of allergic rhinitis have been reported worldwide [11, 12]. The overall prevalence across Europe (Belgium, France, Germany, Italy, Spain and Britain) is about 23%, (lowest in Italy and highest in Belgium) [7]. Using Score for Allergic Rhinitis (SFAR) questionnaire, the prevalence in Turkey is 30% (21% in Southeast Anatolia and 36% in Marmara) [13].

The prevalence of physician-diagnosed allergic rhinitis in five Middle East countries (Egypt, Iran, Lebanon, Saudi Arabia, and UAE) is 9%, with dust being the main trigger [8]. These results are similar to our study, showing a prevalence of 7% and dust being a common trigger (Table 1). Mesquite (leguminous tree of the Prosopis genus) is the most common allergen in Turkey [14].

The prevalence of allergic rhinitis in school children from Saudi Arabia is 24%, Turkey 16%, Kuwait 41%, Lebanon 45%, and Al-Ain city (Abu Dhabi) 36% [9, 1518]. Being an inland desert oasis, Al-Ain city is rich in plantation type plants. It has the highest number of date palms and gardens, which explain the frequent plant-induced allergic rhinitis [9]. Dubai, Umm Al-Quwain and Ajman are desert areas with numerous constructions that produce fine dust. Fujairah contains mountains that are rich in plant life. Ras Al-Khaimah has cement factories and ceramic industries. These environmental variables undoubtedly attribute to the natural history of allergic rhinitis in the region.

Construction produces numerous amounts of fine dust in the air, which is a major source of airway irritation. Consistently, dust is shown here to be a main airway irritant (Tables 1 and 2). Being in a dusty room and exposure to a dusty rug/pillow aggravated the symptoms in 59% of the studied patients (Table 1). Dust mites were a main trigger in patients from Israel, Iran, and Jordan [1921]. Moreover, grass/pollens were found to be a common allergen in patients from Iran and Turkey [22, 23].

Many (44%) patients were poly-sensitized. Thirty-seven (58%) of the patients with a specific trigger had grass/pollens allergy. Dust alone was a trigger in only 22 (26%) patients (Table 1). Seasons and living in the inner city were not significant predictors of dust-induced symptoms (Tables 2 and 3). In contrast, grass/pollens were main triggers for people who identified a season for their symptoms (Table 2).

A high prevalence of allergies in urban (compared to rural) areas was reported in Germany, Poland, and Turkey [2426]. Our inner cities have unique living conditions including high humidity, use of air conditioning, frequent house molds and traffic pollution. Nevertheless, spring allergies were less frequent in people living in the inner city (Table 3, p = 0.003).

Only 46% of the patients made efforts to minimize exposure to dust and dust-mites; only 39% received treatment. Other studies have shown low prevalences of allergic rhinitis treatment (12% in USA, 47% in Europe, and 53% in Middle East) [7, 9, 12]. This practice of not treating patients reflects inadequate allergic rhinitis awareness on the part of doctors and patients. Since allergic rhinitis may be a precursor to (risk factor for) asthma, more emphasis on this disorder is needed.

Study limitations

This study employed the standard ECRHS II for identifying patients with allergic rhinitis. The questionnaire did not address severity of symptoms and did not include a physician diagnosis. Furthermore, this survey was performed in a population with little awareness about allergic rhinitis. Thus, the symptoms might have been underreported. The number of patients was small for sub-analysis by individual Emirates. This important limitation should be addressed in a future study. Follow-up studies should include physician documentations of the allergic symptoms and patients’ response to interventions.

Conclusions

Prevalence of allergic rhinitis in the UAE is at least 7%. Dust and grass/pollens are common triggers. Improving public awareness and implementing preventive measures are necessary for controlling allergic rhinitis in the region.

Declarations

Authors’ Affiliations

(1)
Department of Pulmonary Medicine, Rashid Hospital
(2)
Department of Pediatrics, College of Medicine and Health Sciences, UAE University
(3)
Department of Family & Community Medicine, Sharjah University
(4)
Department of Pediatrics and Medicine, University of Tennessee Health Science Centre
(5)
Department of Otorhinolaryngology, Al-Qassimi Hospital

References

  1. Bousquet J, Khaltaev J, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML: Allergic Rhinitis and its impact on asthma. Allergy. 2008, 63: 7-View ArticleGoogle Scholar
  2. Greiner AN, Hellings PW, Scadding GK: Allergic rhinitis. Lancet. 2011, 378: 2112-2122. 10.1016/S0140-6736(11)60130-X.View ArticlePubMedGoogle Scholar
  3. Mims JW: Allergic rhinitis. Facial Plast Surg Clin North Am. 2012, 20: 11-20. 10.1016/j.fsc.2011.10.002.View ArticlePubMedGoogle Scholar
  4. Hadley JA, Derebery MJ, Marple BF: Comorbidities and allergic rhinitis: not just a runny nose. J Fam Pract. 2012, 61: S11-S15.PubMedGoogle Scholar
  5. Nathan RA, Meltzer EO, Derebery J, Campbell UB, Stang PE, Corrao MA, Allen G, Stanford R: The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in an America survey. Allergy Asthma Proc. 2008, 29: 600-608. 10.2500/aap.2008.29.3179.View ArticlePubMedGoogle Scholar
  6. Janson C, Anto J, Burney P, Chinn S, de Marco R, Heinrich J, Jarvis D, Kuenzli N, Leynaert B, Luczynska C, Neukirch F, Svanes C, Sunyer J, Wjst M: The European Respiratory Health Survey: what are the main results so far. European Respiratory Health Survey II. Eur Resp J. 2001, 18: 598-611. 10.1183/09031936.01.00205801.View ArticleGoogle Scholar
  7. Bauchau V, Durham SR: Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004, 24: 758-764. 10.1183/09031936.04.00013904.View ArticlePubMedGoogle Scholar
  8. Abdulrahman H, Hadi U, Tarraf H, Gharagozlou M, Kamel M, Soliman A, Hamad WA, Hanna KM, Mostafa BE, Omrani M, Abdelmotal A, Moukarzel N: Nasal allergies in the Middle Eastern population: results from the “Allergies in Middle East Survey”. Am J Rhinol Allergy. 2012, 26: 3-23. 10.2500/ajra.2012.26.3836.View ArticleGoogle Scholar
  9. Alsowaidi S, Abdulle A, Shehab A, Zuberbier T, Bernsen R: Allergic rhinitis: prevalence and possible risk factors in a Gulf Arab population. Allergy. 2010, 65: 208-212. 10.1111/j.1398-9995.2009.02123.x.View ArticlePubMedGoogle Scholar
  10. Mahboub BH, Al-Hammadi S, Rafique M, Sulaiman N, Pawankar R, Al Redha AI, Mehta AC: Population prevalence of asthma and its determinants based on European Community Respiratory Health Survey in the United Arab Emirates. BMC Pulm Med. 2012, 12: 4-10.1186/1471-2466-12-4.PubMed CentralView ArticlePubMedGoogle Scholar
  11. Strachan D, Sibbald B, Weiland S, Aït-Khaled N, Anabwani G, Anderson HR, Asher MI, Beasley R, Björkstén B, Burr M, Clayton T, Crane J, Ellwood P, Keil U, Lai C, Mallol J, Martinez F, Mitchell E, Montefort S, Pearce N, Robertson C, Shah J, Stewart A, von Mutius E, Williams H: Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol. 1997, 8: 161-176. 10.1111/j.1399-3038.1997.tb00156.x.View ArticlePubMedGoogle Scholar
  12. Keith PK, Desrosiers M, Laister T, Schellenberg RR, Waserman S: The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients. Allergy Asthma Clin Immunol. 2012, 8: 7-10.1186/1710-1492-8-7.PubMed CentralView ArticlePubMedGoogle Scholar
  13. Cingi C, Songu M, Ural A, Annesi-Maesano I, Erdogmus N, Bal C, Kahya V, Koc EA, Cakir BO, Selcuk A, Ozlugedik S, Onal K, Midilli R, Ecevit C, Pinar E, Akoglu E, Okuyucu S, Erkan AN: The score for allergic rhinitis study in Turkey. Am J Rhinol Allergy. 2011, 25: 333-337. 10.2500/ajra.2011.25.3665.View ArticlePubMedGoogle Scholar
  14. Kurt E, Metintas S, Basyigit I, Bulut I, Coskun E, Dabak S, Deveci F, Fidan F, Kaynar H, Kunt Uzaslan E, Onbasi K, Ozkurt S, Pasaoglu Karakis G, Sahan S, Sahin U, Oguzulgen K, Yildiz F, Mungan D, Yorgancioglu A, Gemicioglu B, Fuat Kalyoncu A: Prevalence and risk factors of allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults. Eur Respir J. 2009, 33: 724-733. 10.1183/09031936.00082207.View ArticlePubMedGoogle Scholar
  15. Nahhas M, Bhopal R, Anandan C, Elton R, Sheikh A: Prevalence of allergic disorders among primary school-aged children in Madinah, Saudi Arabia: two-stage cross-sectional survey. PLoS ONE. 2012, 7: e36848-10.1371/journal.pone.0036848.PubMed CentralView ArticlePubMedGoogle Scholar
  16. Civelek E, Cakir B, Boz AB, Yuksel H, Orhan F, Uner A, Sekerel BE: Extent and burden of allergic diseases in elementary schoolchildren: a national multicenter study. J Investig Allergol Clin Immunol. 2010, 20: 280-288.PubMedGoogle Scholar
  17. Owayed A, Behbehani N, Al-Momen J: Changing prevalence of asthma and allergic diseases among Kuwaiti children. An ISAAC Study (Phase III). Med Princ Pract. 2008, 17: 284-289. 10.1159/000129607.View ArticlePubMedGoogle Scholar
  18. Musharrafieh U, Al-Sahab B, Zaitoun F, El-Hajj MA, Ramadan F, Tamim H: Prevalence of asthma, allergic rhinitis and eczema among Lebanese adolescents. J Asthma. 2009, 46: 382-387. 10.1080/02770900902777775.View ArticlePubMedGoogle Scholar
  19. Zeldin Y, Kidon MI, Magen E, Bibi H, Cohen A, Waisel Y, Kivity S: Impact of specific allergen sensitization on the prevalence of asthma in patients with allergic rhinitis from adjacent distinct geographic areas. Ann Allergy Asthma Immunol. 2008, 101: 30-34. 10.1016/S1081-1206(10)60831-9.View ArticlePubMedGoogle Scholar
  20. Ghaffari J, Khademloo M, Saffar MJ, Rafiei A, Masiha F: Hypersensitivity to house dust mite and cockroach is the most common allergy in north of Iran. Iran J Immunol. 2010, 7: 234-239.PubMedGoogle Scholar
  21. Aburuz S, Bulatova N, Tawalbeh M: Skin prick test reactivity to aeroallergens in Jordanian allergic rhinitis patients. East Mediterr Health J. 2011, 17: 604-610.PubMedGoogle Scholar
  22. Fereidouni M, Hossini RF, Azad FJ, Assarehzadegan MA, Varasteh A: Skin prick test reactivity to common aeroallergens among allergic rhinitis patients in Iran. Allergol Immunopathol (Madr). 2009, 37: 73-79. 10.1016/S0301-0546(09)71108-5.View ArticleGoogle Scholar
  23. Aydin S, Hardal U, Atli H: An analysis of skin prick test reactions in allergic rhinitis patients in Istanbul, Turkey. Asian Pac J Allergy Immunol. 2009, 27: 19-25.PubMedGoogle Scholar
  24. Filipiak B, Heinrich J, Schäfer T, Ring J, Wichmann HE: Farming, rural lifestyle and atopy in adults from southern Germany–results from the MONICA/KORA study Augsburg. Clin Exp Allergy. 2001, 31: 1829-1838. 10.1046/j.1365-2222.2001.01246.x.View ArticlePubMedGoogle Scholar
  25. Majkowska-Wojciechowska B, Pełka J, Korzon L, Korzon L, Kozłowska A, Kaczała M, Jarzebska M, Gwardys T, Kowalski ML: Prevalence of allergy, patterns of allergic sensitization and allergy risk factors in rural and urban children. Allergy. 2007, 62: 1044-1050. 10.1111/j.1398-9995.2007.01457.x.View ArticlePubMedGoogle Scholar
  26. Cingi C, Topuz B, Songu M, Kara CO, Ural A, Yaz A, Yildirim M, Miman MC, Bal C: Prevalence of allergicrhinitis among the adult population in Turkey. Acta Otolaryngol. 2010, 130: 600-606. 10.3109/00016480903311880.View ArticlePubMedGoogle Scholar

Copyright

© Mahboub et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.